Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Schechter

Showing results (201-210 of 265) with videos related to

Pageof 27
Sort By:
Journal of General Internal Medicine|July 1, 2005
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health statusJeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff, et al.
Cancer|December 27, 2017
Distinguishing between CISNET model results versus CISNET modelsDonald A Berry, Harry J de Koning, Sandra J Lee, et al.
BMJ Quality & Safety|December 10, 2023
Retrospective cohort study of wrong-patient imaging order errors: how many reach the patient?Jerard Z Kneifati-Hayek, Elias Geist, Jo R Applebaum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2010
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United StatesNicolien T van Ravesteyn, Clyde B Schechter, Aimee M Near, et al.
The Science of Diabetes Self-Management and Care|May 10, 2024
Outcomes of New York City Care Calls: A Prospective Randomized Controlled Effectiveness Trial of Telephone-Delivered Type 2 Diabetes Self-Management SupportJeffrey S Gonzalez, Claire J Hoogendoorn, Clyde B Schechter, et al.
Journal of the National Cancer Institute|May 8, 2015
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosisNicolien T van Ravesteyn, Natasha K Stout, Clyde B Schechter, et al.
Chest|January 15, 2009
Longitudinal assessment of spirometry in the World Trade Center medical monitoring programGwen S Skloot, Clyde B Schechter, Robin Herbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2018
Cost Effectiveness of Gene Expression Profile Testing in Community PracticeYoung Chandler, Clyde B Schechter, Jinani Jayasekera, et al.
Breast Cancer Research and Treatment|October 30, 2012
Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortalityYaojen Chang, Clyde B Schechter, Nicolien T van Ravesteyn, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 31, 2008
Adiponectin levels and genotype: a potential regulator of life span in humansGil Atzmon, Toni I Pollin, Jill Crandall, et al.
Pageof 27

Showing results (201-210 of 265) with videos related to

Sort By:
Pageof 27
Journal of General Internal Medicine|July 1, 2005
Toward optimal screening strategies for older women. Costs, benefits, and harms of breast cancer screening by age, biology, and health statusJeanne S Mandelblatt, Clyde B Schechter, K Robin Yabroff, et al.
Cancer|December 27, 2017
Distinguishing between CISNET model results versus CISNET modelsDonald A Berry, Harry J de Koning, Sandra J Lee, et al.
BMJ Quality & Safety|December 10, 2023
Retrospective cohort study of wrong-patient imaging order errors: how many reach the patient?Jerard Z Kneifati-Hayek, Elias Geist, Jo R Applebaum, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 2, 2010
Race-specific impact of natural history, mammography screening, and adjuvant treatment on breast cancer mortality rates in the United StatesNicolien T van Ravesteyn, Clyde B Schechter, Aimee M Near, et al.
The Science of Diabetes Self-Management and Care|May 10, 2024
Outcomes of New York City Care Calls: A Prospective Randomized Controlled Effectiveness Trial of Telephone-Delivered Type 2 Diabetes Self-Management SupportJeffrey S Gonzalez, Claire J Hoogendoorn, Clyde B Schechter, et al.
Journal of the National Cancer Institute|May 8, 2015
Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosisNicolien T van Ravesteyn, Natasha K Stout, Clyde B Schechter, et al.
Chest|January 15, 2009
Longitudinal assessment of spirometry in the World Trade Center medical monitoring programGwen S Skloot, Clyde B Schechter, Robin Herbert, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 9, 2018
Cost Effectiveness of Gene Expression Profile Testing in Community PracticeYoung Chandler, Clyde B Schechter, Jinani Jayasekera, et al.
Breast Cancer Research and Treatment|October 30, 2012
Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortalityYaojen Chang, Clyde B Schechter, Nicolien T van Ravesteyn, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 31, 2008
Adiponectin levels and genotype: a potential regulator of life span in humansGil Atzmon, Toni I Pollin, Jill Crandall, et al.
Pageof 27